Novavax reported $-322431000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Adma Biologics ADMA:US $ -17.71M 1.19M
AstraZeneca AZN:LN -1652M 2202M
Astrazeneca AZN:US $ -1652M 2202M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Genocea Biosciences GNCA:US $ -3.62M 0.69M
Geron GERN:US $ -26.7M 2.88M
GlaxoSmithKline GSK:LN 1168M 227M
Kindred Biosciences KIN:US $ -9.13M 0.61M
Mannkind MNKD:US $ -4.43M 31.1M
Merk MRK:US $ 4567M 3022M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Moderna Inc MRNA:US 3.33B 553M
Novartis NVS:US $ 2758M 138M
Novavax NVAX:US $ -322.43M 29.89M
Pain Therapeutics PTIE:US $ -9.56M 4.44M
Peregrine Pharmaceuticals PPHM:US $ 6.3M 4.31M
Pfizer PFE:US $ 8146M 2582M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Tg Therapeutics TGTX:US $ -85.64M 7.14M